Spot Trading’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Spot Trading's BIIB Position: Q3 2017 in Review
Spot Trading sold out of Biogen (BIIB) in Q3 2017, closing a stake of 9,193 shares — an estimated $2.72M sold.
Spot Trading first reported a position in BIIB in Q4 2013 and held it in 12 quarters. The position peaked at $8.26M in Q1 2016. 1,014 funds tracked by Wall St. Rank hold BIIB as of Q3 2017.
- Spot Trading reported no remaining Biogen position as of Q3 2017 after selling out during the quarter.
- Spot Trading sold 9,193 Biogen shares in Q3 2017, an estimated $2.72M.
- Spot Trading first reported a position in Biogen in Q4 2013 and held it in 12 quarters.
- Spot Trading's Biogen position peaked at $8.26M in Q1 2016.
- 1,014 funds tracked by Wall St. Rank held Biogen as of Q3 2017.
Based on Spot Trading's 13F filing for Q3 2017, filed 6 Nov 2017.